Clinical Trial Update: Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing a chemotherapy combination (cisplatin-fluorouracil-afatinib) in patients with inoperable gastric or gastroesophageal junction cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Cisplatin-FU-Afatinib combination

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | Status: COMPLETED